Malcolm C. Pike, who has joined Memorial Sloan-Kettering’s Epidemiology Service, is a renowned epidemiologist who has made seminal contributions to the understanding of hormone-related breast cancer. His research addresses key public health issues such as those relating to oral contraceptives and breast cancer. Dr. Pike received his PhD degree in mathematical statistics in 1963 from Aberdeen University, in Scotland. Dr. Pike was previously the Director of the Cancer Epidemiology Unit at Oxford University from 1983 to 1987 and comes to Memorial Sloan-Kettering from the USC/Norris Comprehensive Cancer Center, where he was University Professor of Preventive Medicine. His many honors include membership in the Institute of Medicine and the 2008 Distinguished Achievement Award from the American Society of Preventive Oncology.